Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    September 2022
  1. SIN DD
    RETHINCking COPD - Bronchodilators for Symptomatic Tobacco-Exposed Persons with Preserved Lung Function?
    N Engl J Med. 2022;387:1230-1231.
    PubMed    


  2. HAN MK, Ye W, Wang D, White E, et al
    Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.
    N Engl J Med. 2022;387:1173-1184.
    PubMed     Abstract available


    August 2022
  3. RASIAH S, Whitchurch M
    Severe Subcutaneous Emphysema.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMicm2200611.
    PubMed    


  4. PAPI A, Chipps BE, Cappelletti C
    Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. Reply.
    N Engl J Med. 2022;387:663.
    PubMed    


  5. LIPWORTH BJ, Chan R, Stewart KE
    Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
    N Engl J Med. 2022;387:662-663.
    PubMed    


  6. O'DONNELL AE
    Bronchiectasis - A Clinical Review.
    N Engl J Med. 2022;387:533-545.
    PubMed    


    June 2022
  7. SCHATZ M
    Another Rescue Therapy Option for Patients with Moderate-to-Severe Asthma.
    N Engl J Med. 2022;386:2139-2140.
    PubMed    


    May 2022
  8. PAPI A, Chipps BE, Beasley R, Panettieri RA Jr, et al
    Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
    N Engl J Med. 2022 May 15. doi: 10.1056/NEJMoa2203163.
    PubMed     Abstract available


  9. TRAVER EC, Gao NJ
    Emphysematous Aortitis.
    N Engl J Med. 2022;386:1833.
    PubMed    


    April 2022
  10. BRYANT-STEPHENS T
    Breaking the Skin Color Barriers for Asthma Medications - It's Not Black, Brown, or White.
    N Engl J Med. 2022;386:1574-1575.
    PubMed    


    March 2022
  11. KING TE JR, Lee JS
    Cryptogenic Organizing Pneumonia.
    N Engl J Med. 2022;386:1058-1069.
    PubMed    


    February 2022
  12. ISRAEL E, Cardet JC, Carroll JK, Fuhlbrigge AL, et al
    Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma.
    N Engl J Med. 2022 Feb 26. doi: 10.1056/NEJMoa2118813.
    PubMed     Abstract available


  13. MAQSOOD A, Imel LR
    Plastic Bronchitis.
    N Engl J Med. 2022;386:780.
    PubMed    


  14. MEHTA I, Patel K
    Lymphatic Plastic Bronchitis.
    N Engl J Med. 2022;386:e19.
    PubMed    


    January 2022
  15. BRUSSELLE GG, Koppelman GH
    Biologic Therapies for Severe Asthma.
    N Engl J Med. 2022;386:157-171.
    PubMed    


    December 2021
  16. GONZALEZ BURCHARD E, Borrell LN
    Need for Racial and Ethnic Diversity in Asthma Precision Medicine.
    N Engl J Med. 2021;385:2297-2298.
    PubMed    


  17. BACHARIER LB, Maspero JF, Katelaris CH, Fiocchi AG, et al
    Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
    N Engl J Med. 2021;385:2230-2240.
    PubMed     Abstract available


    October 2021
  18. BARDIN PG, Foster PS
    Clinical Translation of Basic Science in Asthma.
    N Engl J Med. 2021;385:1714-1717.
    PubMed    


  19. BRIGHTLING CE, Nair P, Cousins DJ, Louis R, et al
    Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial.
    N Engl J Med. 2021;385:1669-1679.
    PubMed     Abstract available


  20. WECHSLER ME, Ruddy MK, Pavord ID, Israel E, et al
    Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.
    N Engl J Med. 2021;385:1656-1668.
    PubMed     Abstract available


  21. BOFILL A, Marco F
    Emphysematous Hepatitis.
    N Engl J Med. 2021;385:e58.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: